Kpv Peptide Supplier
Selecting a qualified KPV peptide supplier is a critical prerequisite for generating reproducible data in preclinical inflammation and mucosal barrier research. PX1 Research supplies high-purity Lys-Pro-Val tripeptide accompanied by comprehensive, lot-specific analytical verification. Manufactured in domestic GMP-compliant facilities, our compounds undergo independent purity testing to meet the rigorous demands of institutional laboratories.
Quick answer
Selecting a qualified KPV peptide supplier is a critical prerequisite for generating reproducible data in preclinical inflammation and mucosal barrier research. PX1 Research supplies high-purity Lys-Pro-Val tripeptide accompanied by comprehensive, lot-specific analytical verification. Manufactured in domestic GMP-compliant facilities, our compounds undergo independent purity testing to meet the rigorous demands of institutional laboratories.
Key takeaways
- A reliable [KPV](/research-peptides/kpv) peptide supplier must provide fully verified, high-purity Lys-Pro-Val (KPV) tripeptide backed by transparent, lot-specific documentation.
- [KPV](/research-peptides/kpv) is a synthetic tripeptide consisting of the amino acid sequence L-lysine, L-proline, and L-valine.
- Preclinical investigations demonstrate that [KPV](/research-peptides/kpv) exerts its anti-inflammatory effects primarily through the intracellular inhibition of nuclear factor kappa B (NF-κB) activation.
- The primary focus of contemporary [KPV](/research-peptides/kpv) literature centers on gastrointestinal pathophysiology and epithelial barrier preservation.
Selecting a Verified KPV Peptide Supplier for Preclinical Research
A reliable KPV peptide supplier must provide fully verified, high-purity Lys-Pro-Val (KPV) tripeptide backed by transparent, lot-specific documentation. For academic and corporate research laboratories evaluating inflammatory signaling, mucosal integrity, or cytokine inhibition, obtaining a research compound with guaranteed sequence fidelity and minimal endotoxin contamination is essential for experimental validity.
PX1 Research operates as a dedicated USA-based supplier of analytical-grade compounds, offering institutional researchers direct access to high-purity KPV peptide batches. Every lot is subjected to rigorous quality control frameworks, including reverse-phase high-performance liquid chromatography (RP-HPLC) and electrospray ionization mass spectrometry (ESI-MS), ensuring that laboratory investigators receive pure, unadulterated material for demanding in vitro and in vivo models.
Molecular Structure and Chemical Identity of Lys-Pro-Val (KPV)
KPV is a synthetic tripeptide consisting of the amino acid sequence L-lysine, L-proline, and L-valine. Chemically designated as Lys-Pro-Val, it represents the C-terminal amino acid sequence (residues 11–13) of alpha-melanocyte-stimulating hormone (α-MSH). With a molecular formula of C16H30N4O4 and a molecular weight of approximately 342.44 g/mol, KPV is a compact, hydrophilic peptide capable of traversing biological membranes under specific experimental parameters.
Unlike its parent molecule α-MSH, KPV retains potent anti-inflammatory properties without inducing significant pigmentary responses. This structural dissociation allows investigators exploring our broad catalog of research peptides to isolate cytokine-modulating pathways from melanocortin receptor-1 (MC1R) pigmentary cascades, making KPV a focused tool for biophysical and molecular studies.
Mechanisms of Action: NF-κB Modulation and Cytokine Suppression
Preclinical investigations demonstrate that KPV exerts its anti-inflammatory effects primarily through the intracellular inhibition of nuclear factor kappa B (NF-κB) activation. In vitro cell culture models indicate that KPV can cross the plasma membrane—often facilitated by solute carrier transporters such as PepT1—to directly interact with intracellular signaling targets.
Once internalised, KPV inhibits the translocation of the NF-κB p65 subunit to the nucleus, thereby downregulating the transcription of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6). Researchers examining alpha-MSH signaling studies frequently utilize KPV to evaluate downstream anti-inflammatory mechanisms in the absence of full-length peptide receptor cross-reactivity.
Preclinical Literature: Intestinal Barrier Integrity and Colitis Models
The primary focus of contemporary KPV literature centers on gastrointestinal pathophysiology and epithelial barrier preservation. In rodent models of dextran sulfate sodium (DSS)-induced colitis, administration of KPV has been shown to reduce mucosal tissue damage, attenuate neutrophil infiltration (measured via myeloperoxidase assays), and preserve tight junction proteins such as ZO-1 and occludin.
In vitro intestinal epithelial monolayer studies (using Caco-2 cell lines) demonstrate that KPV helps maintain transepithelial electrical resistance (TEER) under inflammatory challenge. These findings, detailed within our growing preclinical research hub, suggest that KPV provides a targeted chemical framework for investigating novel therapeutic targets in inflammatory bowel disease (IBD) and compromised epithelial boundary states.
Comparative Analysis: KPV vs. Related Anti-Inflammatory Peptides
When designing comparative research protocols, investigators often evaluate KPV alongside other well-characterized anti-inflammatory and tissue repair compounds. KPV uniquely targets intracellular NF-κB nuclear translocation, whereas BPC-157 operates primarily through angiogenic upregulation, focal adhesion kinase signaling, and growth factor expression. Furthermore, while the host defense peptide LL-37 modulates inflammatory responses via direct lipopolysaccharide (LPS) neutralization and innate immune activation, KPV offers a non-immunogenic tripeptide backbone focused specifically on pathway inhibition.
Additionally, when contrasted with larger regenerative peptides such as TB-500, which acts via actin sequestration and cell migration pathways, KPV exhibits a significantly lower molecular weight and distinct physical solubility properties. Selecting the appropriate compound depends on whether the laboratory model prioritizes cytoskeletal remodeling, vascularization, or localized nuclear transcription blockade.
Evaluating Quality Attributes in a KPV Supplier
Sourcing research compounds requires rigorous vendor evaluation to prevent contaminated, degraded, or misidentified peptides from compromising experimental data. A high-caliber KPV peptide supplier must fulfill specific quality benchmarks across manufacturing, analysis, and logistics:
1. Domestic Synthesis & Storage: Manufacturing in USA-based, ISO 17025-accredited or GMP-compliant facilities guarantees strict control over precursor reagents and solvent removal. 2. Independent HPLC Verification: High-performance liquid chromatography must confirm a minimum chemical purity of 98.0%, ensuring the absence of deletion sequences or residual protecting groups. 3. Mass Spectrometry Validation: Electrospray ionization mass spectrometry (ESI-MS) must accurately confirm the molecular weight (342.44 Da). 4. Endotoxin Quantification: Limulus Amebocyte Lysate (LAL) testing must confirm low endotoxin levels (<0.01 EU/mg) to prevent false-positive inflammatory readouts in cell assays. 5. Supply Chain Control: Direct-from-manufacturer dispatch prevents freeze-thaw degradation during prolonged transit.
Deciphering Certificate of Analysis (COA) Metrics for KPV
A valid Certificate of Analysis (COA) is the primary proof of peptide quality. When reviewing analytical documentation from a supplier, researchers should inspect the chromatogram baseline and peak area integration values. On an RP-HPLC trace, the primary KPV peak must account for ≥98% of the total integrated area, with trace impurities strictly limited.
Detailed HPLC and mass spectrometry testing reports should also quantify residual trifluoroacetic acid (TFA), a common counterion used during solid-phase peptide synthesis (SPPS). High residual TFA levels can exert cytotoxic effects on primary cell cultures; thus, specialized processing or acetate salt conversion documentation should be requested for sensitive biological assays.
Laboratory Handling, Reconstitution, and Solution Stability
Lyophilized KPV tripeptide is highly hygroscopic and should be stored at -20°C or -80°C in a desiccated container upon receipt. Prior to opening the vial, allow the container to equilibrate to room temperature to prevent condensation from dissolving the dry peptide cake.
For reconstitution, KPV exhibits excellent solubility in sterile laboratory-grade water, phosphate-buffered saline (PBS, pH 7.4), or dimethyl sulfoxide (DMSO) for high-concentration stock solutions. Reconstituted solutions should be divided into single-use aliquots and stored at -80°C to minimize degradation from repeated freeze-thaw cycles. Working solutions kept at 4°C should be utilized within 24 to 48 hours to maintain optimal molecular stability.
Endotoxin Standards for Cellular and In Vivo Assays
Endotoxins (lipopolysaccharides derived from Gram-negative bacterial outer membranes) represent a severe confounding variable in anti-inflammatory research. Because KPV is specifically evaluated for its capacity to reduce cellular inflammation, elevated endotoxin levels in the reagent will trigger Toll-Like Receptor 4 (TLR4) activation, completely masking or distorting KPV's inhibitory effects on NF-κB.
PX1 Research enforces strict endotoxin screening protocols across all batches. By verifying that endotoxin levels remain below 0.01 EU/mg, researchers can confidently attribute observed reductions in inflammatory markers to the biological activity of the KPV molecule itself rather than batch-to-batch artifact fluctuations.
Procurement Protocols and Institutional Wholesale Accounts
To support long-term academic trials and high-throughput screening initiatives, PX1 Research provides streamlined institutional supply options. Qualified academic, clinical, and corporate research bodies can establish bulk institutional procurement agreements to secure consistent single-lot batches, eliminating lot-to-lot variability across multi-phase studies.
All orders ship directly from our domestic distribution centers in California and Arizona. With same-day dispatch for orders placed before standard cutoff times, PX1 Research minimizes transit delays and ensures cold-chain integrity from synthesis to laboratory bench top.
Frequently Asked Questions
What is the sequence and chemical identity of KPV peptide?
KPV is a tripeptide consisting of the sequence Lysine-Proline-Valine (Lys-Pro-Val). It corresponds to the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH) and has a molecular weight of 342.44 g/mol.
What primary mechanisms are studied with KPV in preclinical research?
Preclinical studies focus on KPV's capacity to enter cells via PepT1 transporters and inhibit NF-κB nuclear translocation, resulting in the downregulation of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6.
Why is lot-specific HPLC and MS testing required for KPV?
RP-HPLC confirms chemical purity (≥98%), ensuring deletion sequences or residual synthesis chemicals are absent. Mass spectrometry confirms exact molecular mass identity, ensuring researchers receive genuine, unadulterated Lys-Pro-Val.
What endotoxin limit does PX1 Research guarantee for KPV?
PX1 Research verifies that KPV lots meet an endotoxin threshold of <0.01 EU/mg via LAL testing, preventing TLR4 activation artifacts in sensitive cell culture models.
How should lyophilized KPV be stored upon arrival?
Lyophilized KPV should be stored at -20°C or -80°C in a desiccated environment. Vials should equilibrate to room temperature before opening to prevent atmospheric moisture condensation.
What solvents are suitable for reconstituting KPV in the lab?
KPV easily dissolves in sterile research-grade water or phosphate-buffered saline (PBS, pH 7.4). For high-concentration master stock solutions, DMSO can also be utilized.
Where does PX1 Research manufacture and ship its KPV peptide?
PX1 Research compounds are USA-manufactured in cGMP-compliant facilities. Orders are dispatched same-day (Monday through Friday) from fulfillment centers located in California and Arizona.
Does PX1 Research offer bulk purchasing for institutional labs?
Yes, PX1 Research provides institutional accounts and bulk procurement options for research organizations requiring single-lot consistency across large-scale experimental cohorts.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.